{"transactions":[{"id":4630726,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2353,"kind":"person","name":"Hopman Mark","position":1,"cik":"0002048497","reported_name":"Hopman Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-10-05T21:11:13.000Z","date":"2026-10-01","kind":"sale","planned":false,"acquired":false,"shares":370,"price":18.96,"value":7015.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on June 10, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $18.96 and the range of prices were between $18.96 and $19.9599. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":56109,"source":{"system":"sec-edgar","filing":"0002048497-26-000018","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2048497/000204849726000018/primarydocument.xml","form_type":"4"}},{"id":4625665,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":35373,"kind":"person","name":"Jones Christy","position":1,"cik":"0002048467","reported_name":"Jones Christy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-23T21:40:52.000Z","date":"2026-09-22","kind":"sale","planned":true,"acquired":false,"shares":6430,"price":23,"value":147890.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on February 19, 2026."}],"balance_after":19564,"source":{"system":"sec-edgar","filing":"0002048467-26-000007","document":"form4-09232026_090948.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2048467/000204846726000007/form4-09232026_090948.xml","form_type":"4"}},{"id":4622937,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2353,"kind":"person","name":"Hopman Mark","position":1,"cik":"0002048497","reported_name":"Hopman Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-09-18T23:51:40.000Z","date":"2026-09-09","kind":"sale","planned":true,"acquired":false,"shares":35994,"price":18.4628,"value":664550.0232,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on June 10, 2026 (the \"10b5-1 Plan\")."},{"field":"shares","element":"transactionShares","label":"F2","text":"On September 10, 2026, the reporting person filed a Form 4 which incorrectly reported the number of shares disposed. The reporting person sold 35,994 shares under the 10b5-1 Plan on September 9, 2026 and the number of securities beneficially owned following the sale was 88,033 shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On September 10, 2026, the reporting person filed a Form 4 which incorrectly reported the number of shares disposed. The reporting person sold 35,994 shares under the 10b5-1 Plan on September 9, 2026 and the number of securities beneficially owned following the sale was 88,033 shares."}],"balance_after":88033,"source":{"system":"sec-edgar","filing":"0002048497-26-000016","document":"form4a-09182026_110936.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2048497/000204849726000016/form4a-09182026_110936.xml","form_type":"4/A","original_submission_date":"2026-09-10"}},{"id":4621187,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2353,"kind":"person","name":"Hopman Mark","position":1,"cik":"0002048497","reported_name":"Hopman Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-09-17T20:15:14.000Z","date":"2026-09-16","kind":"sale","planned":true,"acquired":false,"shares":30779,"price":20.1319,"value":619639.7501,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on June 10, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $20.1319 and the range of prices were between $20.00 and $20.64. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":56479,"source":{"system":"sec-edgar","filing":"0002048497-26-000015","document":"form4-09172026_040905.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2048497/000204849726000015/form4-09172026_040905.xml","form_type":"4"}},{"id":4621190,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2351,"kind":"person","name":"Mensinger Mike","position":1,"cik":"0002048500","reported_name":"Mensinger Mike","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Product Officer"}}],"security":"Common Stock","published_at":"2026-09-17T20:15:13.000Z","date":"2026-09-16","kind":"sale","planned":true,"acquired":false,"shares":2650,"price":22,"value":58300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on September 8, 2025."}],"balance_after":177390,"source":{"system":"sec-edgar","filing":"0002048500-26-000013","document":"form4-09172026_040904.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2048500/000204850026000013/form4-09172026_040904.xml","form_type":"4"}},{"id":4617984,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2353,"kind":"person","name":"Hopman Mark","position":1,"cik":"0002048497","reported_name":"Hopman Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-09-15T20:15:22.000Z","date":"2026-09-14","kind":"sale","planned":true,"acquired":false,"shares":775,"price":15.52,"value":12028.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on June 10, 2026."}],"balance_after":86382,"source":{"system":"sec-edgar","filing":"0002048497-26-000014","document":"form4-09152026_040906.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2048497/000204849726000014/form4-09152026_040906.xml","form_type":"4"}},{"id":4614716,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2353,"kind":"person","name":"Hopman Mark","position":1,"cik":"0002048497","reported_name":"Hopman Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-09-10T20:30:09.000Z","date":"2026-09-09","kind":"sale","planned":true,"acquired":false,"shares":36870,"price":18.4628,"value":680723.436,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on June 10, 2026."}],"balance_after":87157,"source":{"system":"sec-edgar","filing":"0002048497-26-000013","document":"form4-09102026_040903.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2048497/000204849726000013/form4-09102026_040903.xml","form_type":"4"}},{"id":4782,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2356,"kind":"person","name":"Saint Sean","position":1,"cik":"0002048593","reported_name":"Saint Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-09-04T21:19:25.000Z","date":"2026-09-03","kind":"sale","planned":true,"acquired":false,"shares":5641,"price":20.0778,"value":113258.8698,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on September 5, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $20.0778 and the range of prices were between $20.00 and $20.1696. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":398429,"source":{"system":"sec-edgar","filing":"0002048593-26-000010","document":"form4-09042026_090921.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2048593/000204859326000010/form4-09042026_090921.xml","form_type":"4"}},{"id":3383,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2353,"kind":"person","name":"Hopman Mark","position":1,"cik":"0002048497","reported_name":"Hopman Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-09-03T22:15:14.000Z","date":"2026-09-02","kind":"sale","planned":false,"acquired":false,"shares":5327,"price":19.1131,"value":101815.4837,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $19.1131 and the range of prices were between $18.89 and $19.545. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":124027,"source":{"system":"sec-edgar","filing":"0002048497-26-000012","document":"form4-09032026_060908.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2048497/000204849726000012/form4-09032026_060908.xml","form_type":"4"}},{"id":3384,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2355,"kind":"person","name":"Russell Steven Jon","position":1,"cik":"0002051384","reported_name":"Russell Steven Jon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-09-03T22:15:12.000Z","date":"2026-09-02","kind":"sale","planned":false,"acquired":false,"shares":4221,"price":19.1131,"value":80676.3951,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $19.1131 and the range of prices were between $18.89 and $19.545. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":169628,"source":{"system":"sec-edgar","filing":"0002051384-26-000009","document":"form4-09032026_060906.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2051384/000205138426000009/form4-09032026_060906.xml","form_type":"4"}},{"id":3381,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2351,"kind":"person","name":"Mensinger Mike","position":1,"cik":"0002048500","reported_name":"Mensinger Mike","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Product Officer"}}],"security":"Common Stock","published_at":"2026-09-03T22:15:11.000Z","date":"2026-09-02","kind":"sale","planned":false,"acquired":false,"shares":4375,"price":19.1131,"value":83619.8125,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $19.1131 and the range of prices were between $18.89 and $19.545. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":180040,"source":{"system":"sec-edgar","filing":"0002048500-26-000012","document":"form4-09032026_060904.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2048500/000204850026000012/form4-09032026_060904.xml","form_type":"4"}},{"id":3382,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-09-03T22:15:08.000Z","date":"2026-09-02","kind":"sale","planned":false,"acquired":false,"shares":6675,"price":19.1131,"value":127579.9425,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $19.1131 and the range of prices were between $18.89 and $19.545. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":159378,"source":{"system":"sec-edgar","filing":"0002048588-26-000013","document":"form4-09032026_060903.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2048588/000204858826000013/form4-09032026_060903.xml","form_type":"4"}},{"id":3385,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2356,"kind":"person","name":"Saint Sean","position":1,"cik":"0002048593","reported_name":"Saint Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-09-03T22:15:05.000Z","date":"2026-09-02","kind":"sale","planned":false,"acquired":false,"shares":16867,"price":19.1131,"value":322380.6577,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $19.1131 and the range of prices were between $18.89 and $19.545. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":404070,"source":{"system":"sec-edgar","filing":"0002048593-26-000009","document":"form4-09032026_060901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2048593/000204859326000009/form4-09032026_060901.xml","form_type":"4"}},{"id":717983,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-07-02T22:44:29.000Z","date":"2026-06-29","kind":"exercise","planned":true,"acquired":false,"shares":4896,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This Form 4 is being amended to correct the number of shares subject to the option exercise that occurred on June 26, 2026, in connection with the reported sales and to correct the number of securities beneficially owned following the reported transactions."}],"balance_after":39695,"derivative":{"exercise_price":5.1,"expiration_date":"2033-09-13","underlying":"Common Stock","underlying_shares":4896},"source":{"system":"sec-edgar","filing":"0002048588-26-000010","document":"form4a-07022026_100725.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204858826000010/form4a-07022026_100725.xml","form_type":"4/A","original_submission_date":"2026-06-30"}},{"id":717982,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-07-02T22:44:29.000Z","date":"2026-06-26","kind":"exercise","planned":true,"acquired":false,"shares":5104,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This Form 4 is being amended to correct the number of shares subject to the option exercise that occurred on June 26, 2026, in connection with the reported sales and to correct the number of securities beneficially owned following the reported transactions."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"This Form 4 is being amended to correct the number of shares subject to the option exercise that occurred on June 26, 2026, in connection with the reported sales and to correct the number of securities beneficially owned following the reported transactions."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This Form 4 is being amended to correct the number of shares subject to the option exercise that occurred on June 26, 2026, in connection with the reported sales and to correct the number of securities beneficially owned following the reported transactions."}],"balance_after":44591,"derivative":{"exercise_price":5.1,"expiration_date":"2033-09-13","underlying":"Common Stock","underlying_shares":5104},"source":{"system":"sec-edgar","filing":"0002048588-26-000010","document":"form4a-07022026_100725.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204858826000010/form4a-07022026_100725.xml","form_type":"4/A","original_submission_date":"2026-06-30"}},{"id":717981,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-07-02T22:44:29.000Z","date":"2026-06-29","kind":"sale","planned":true,"acquired":false,"shares":4896,"price":17.0304,"value":83380.8384,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 15, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The weighted average sale price for the transaction reported was $17.0304 and the range of prices were between $17 and $17.08. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This Form 4 is being amended to correct the number of shares subject to the option exercise that occurred on June 26, 2026, in connection with the reported sales and to correct the number of securities beneficially owned following the reported transactions."}],"balance_after":166053,"source":{"system":"sec-edgar","filing":"0002048588-26-000010","document":"form4a-07022026_100725.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204858826000010/form4a-07022026_100725.xml","form_type":"4/A","original_submission_date":"2026-06-30"}},{"id":717980,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-07-02T22:44:29.000Z","date":"2026-06-29","kind":"exercise","planned":true,"acquired":true,"shares":4896,"price":5.1,"value":24969.6,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This Form 4 is being amended to correct the number of shares subject to the option exercise that occurred on June 26, 2026, in connection with the reported sales and to correct the number of securities beneficially owned following the reported transactions."}],"balance_after":170949,"source":{"system":"sec-edgar","filing":"0002048588-26-000010","document":"form4a-07022026_100725.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204858826000010/form4a-07022026_100725.xml","form_type":"4/A","original_submission_date":"2026-06-30"}},{"id":717979,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-07-02T22:44:29.000Z","date":"2026-06-26","kind":"sale","planned":true,"acquired":false,"shares":5104,"price":17.0467,"value":87006.3568,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 15, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The weighted average sale price for the transaction reported was $17.046782 and the range of prices were between $17 and $17.12. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This Form 4 is being amended to correct the number of shares subject to the option exercise that occurred on June 26, 2026, in connection with the reported sales and to correct the number of securities beneficially owned following the reported transactions."}],"balance_after":166053,"source":{"system":"sec-edgar","filing":"0002048588-26-000010","document":"form4a-07022026_100725.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204858826000010/form4a-07022026_100725.xml","form_type":"4/A","original_submission_date":"2026-06-30"}},{"id":717978,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-07-02T22:44:29.000Z","date":"2026-06-26","kind":"exercise","planned":true,"acquired":true,"shares":5104,"price":5.1,"value":26030.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This Form 4 is being amended to correct the number of shares subject to the option exercise that occurred on June 26, 2026, in connection with the reported sales and to correct the number of securities beneficially owned following the reported transactions."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This Form 4 is being amended to correct the number of shares subject to the option exercise that occurred on June 26, 2026, in connection with the reported sales and to correct the number of securities beneficially owned following the reported transactions."}],"balance_after":171157,"source":{"system":"sec-edgar","filing":"0002048588-26-000010","document":"form4a-07022026_100725.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204858826000010/form4a-07022026_100725.xml","form_type":"4/A","original_submission_date":"2026-06-30"}},{"id":722783,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-06-30T20:46:09.000Z","date":"2026-06-29","kind":"exercise","planned":true,"acquired":false,"shares":4896,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023."}],"balance_after":39817,"derivative":{"exercise_price":5.1,"expiration_date":"2033-09-13","underlying":"Common Stock","underlying_shares":4896},"source":{"system":"sec-edgar","filing":"0002048588-26-000009","document":"form4-06302026_080605.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204858826000009/form4-06302026_080605.xml","form_type":"4"}},{"id":722782,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-06-30T20:46:09.000Z","date":"2026-06-26","kind":"exercise","planned":true,"acquired":false,"shares":4982,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023."}],"balance_after":44713,"derivative":{"exercise_price":5.1,"expiration_date":"2033-09-13","underlying":"Common Stock","underlying_shares":4982},"source":{"system":"sec-edgar","filing":"0002048588-26-000009","document":"form4-06302026_080605.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204858826000009/form4-06302026_080605.xml","form_type":"4"}},{"id":722781,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-30T20:46:09.000Z","date":"2026-06-29","kind":"sale","planned":true,"acquired":false,"shares":4896,"price":17.0304,"value":83380.8384,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 15, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The weighted average sale price for the transaction reported was $17.0304 and the range of prices were between $17 and $17.08. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":165931,"source":{"system":"sec-edgar","filing":"0002048588-26-000009","document":"form4-06302026_080605.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204858826000009/form4-06302026_080605.xml","form_type":"4"}},{"id":722780,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-30T20:46:09.000Z","date":"2026-06-29","kind":"exercise","planned":true,"acquired":true,"shares":4896,"price":5.1,"value":24969.6,"ownership":{"direct":true},"balance_after":170827,"source":{"system":"sec-edgar","filing":"0002048588-26-000009","document":"form4-06302026_080605.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204858826000009/form4-06302026_080605.xml","form_type":"4"}},{"id":722779,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-30T20:46:09.000Z","date":"2026-06-26","kind":"sale","planned":true,"acquired":false,"shares":5104,"price":17.0467,"value":87006.3568,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 15, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $17.046782 and the range of prices were between $17 and $17.12. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":165931,"source":{"system":"sec-edgar","filing":"0002048588-26-000009","document":"form4-06302026_080605.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204858826000009/form4-06302026_080605.xml","form_type":"4"}},{"id":722778,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-30T20:46:09.000Z","date":"2026-06-26","kind":"exercise","planned":true,"acquired":true,"shares":4982,"price":5.1,"value":25408.2,"ownership":{"direct":true},"balance_after":171035,"source":{"system":"sec-edgar","filing":"0002048588-26-000009","document":"form4-06302026_080605.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204858826000009/form4-06302026_080605.xml","form_type":"4"}},{"id":726378,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2353,"kind":"person","name":"Hopman Mark","position":1,"cik":"0002048497","reported_name":"Hopman Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-06-25T20:34:10.000Z","date":"2026-06-24","kind":"sale","planned":true,"acquired":false,"shares":1258,"price":15.0083,"value":18880.4414,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 13, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $15.0083 and the range of prices were between $15.00 and $15.015. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":129354,"source":{"system":"sec-edgar","filing":"0002048497-26-000009","document":"form4-06252026_080606.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204849726000009/form4-06252026_080606.xml","form_type":"4"}},{"id":726375,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":35373,"kind":"person","name":"Jones Christy","position":1,"cik":"0002048467","reported_name":"Jones Christy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-25T20:32:30.000Z","date":"2026-06-24","kind":"sale","planned":true,"acquired":false,"shares":1406,"price":15,"value":21090.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on February 19, 2026."}],"balance_after":25994,"source":{"system":"sec-edgar","filing":"0002048467-26-000005","document":"form4-06252026_080626.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204846726000005/form4-06252026_080626.xml","form_type":"4"}},{"id":747940,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2353,"kind":"person","name":"Hopman Mark","position":1,"cik":"0002048497","reported_name":"Hopman Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-06-05T22:05:07.000Z","date":"2026-06-04","kind":"sale","planned":true,"acquired":false,"shares":275,"price":12.31,"value":3385.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 13, 2025."}],"balance_after":130612,"source":{"system":"sec-edgar","filing":"0002048497-26-000008","document":"form4-06052026_060603.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204849726000008/form4-06052026_060603.xml","form_type":"4"}},{"id":747939,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":35373,"kind":"person","name":"Jones Christy","position":1,"cik":"0002048467","reported_name":"Jones Christy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-05T22:05:05.000Z","date":"2026-06-04","kind":"sale","planned":true,"acquired":false,"shares":2811,"price":14,"value":39354.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on February 19, 2026."}],"balance_after":27400,"source":{"system":"sec-edgar","filing":"0002048467-26-000004","document":"form4-06052026_060601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204846726000004/form4-06052026_060601.xml","form_type":"4"}},{"id":751753,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2351,"kind":"person","name":"Mensinger Mike","position":1,"cik":"0002048500","reported_name":"Mensinger Mike","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Product Officer"}}],"security":"Common Stock","published_at":"2026-06-03T22:13:50.000Z","date":"2026-06-02","kind":"sale","planned":false,"acquired":false,"shares":4378,"price":12.6071,"value":55193.8838,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $12.6071 and the range of prices were between $12.30 and $12.93. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":184415,"source":{"system":"sec-edgar","filing":"0002048500-26-000009","document":"form4-06032026_100646.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204850026000009/form4-06032026_100646.xml","form_type":"4"}},{"id":751752,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2353,"kind":"person","name":"Hopman Mark","position":1,"cik":"0002048497","reported_name":"Hopman Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-06-03T22:00:12.000Z","date":"2026-06-02","kind":"sale","planned":false,"acquired":false,"shares":5329,"price":12.6071,"value":67183.2359,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $12.6071 and the range of prices were between $12.30 and $12.93. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":130887,"source":{"system":"sec-edgar","filing":"0002048497-26-000007","document":"form4-06032026_060607.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204849726000007/form4-06032026_060607.xml","form_type":"4"}},{"id":752359,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2355,"kind":"person","name":"Russell Steven Jon","position":1,"cik":"0002051384","reported_name":"Russell Steven Jon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-06-03T22:00:11.000Z","date":"2026-06-02","kind":"sale","planned":false,"acquired":false,"shares":4222,"price":12.6071,"value":53227.1762,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $12.6071 and the range of prices were between $12.30 and $12.93. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":173849,"source":{"system":"sec-edgar","filing":"0002051384-26-000006","document":"form4-06032026_060605.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2051384/000205138426000006/form4-06032026_060605.xml","form_type":"4"}},{"id":751751,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-03T22:00:09.000Z","date":"2026-06-02","kind":"sale","planned":false,"acquired":false,"shares":6676,"price":12.6071,"value":84164.9996,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $12.6071 and the range of prices were between $12.30 and $12.93. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":166053,"source":{"system":"sec-edgar","filing":"0002048588-26-000008","document":"form4-06032026_060603.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204858826000008/form4-06032026_060603.xml","form_type":"4"}},{"id":751750,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2356,"kind":"person","name":"Saint Sean","position":1,"cik":"0002048593","reported_name":"Saint Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-06-03T22:00:08.000Z","date":"2026-06-02","kind":"sale","planned":false,"acquired":false,"shares":16872,"price":12.6071,"value":212706.9912,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $12.6071 and the range of prices were between $12.30 and $12.93. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":420937,"source":{"system":"sec-edgar","filing":"0002048593-26-000006","document":"form4-06032026_060601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204859326000006/form4-06032026_060601.xml","form_type":"4"}},{"id":763762,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":44224,"kind":"person","name":"MICHEL GERARD J","position":1,"cik":"0001235644","reported_name":"MICHEL GERARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-26T22:00:38.000Z","date":"2026-05-21","kind":"grant","planned":false,"acquired":true,"shares":16965,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan."}],"balance_after":33509,"source":{"system":"sec-edgar","filing":"0001235644-26-000008","document":"form4-05262026_060533.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000123564426000008/form4-05262026_060533.xml","form_type":"4"}},{"id":763761,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":35373,"kind":"person","name":"Jones Christy","position":1,"cik":"0002048467","reported_name":"Jones Christy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-26T22:00:35.000Z","date":"2026-05-21","kind":"grant","planned":true,"acquired":true,"shares":16965,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan."}],"balance_after":30211,"source":{"system":"sec-edgar","filing":"0002048467-26-000003","document":"form4-05262026_060530.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204846726000003/form4-05262026_060530.xml","form_type":"4"}},{"id":763760,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":35373,"kind":"person","name":"Jones Christy","position":1,"cik":"0002048467","reported_name":"Jones Christy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-26T22:00:35.000Z","date":"2026-05-21","kind":"sale","planned":true,"acquired":false,"shares":1998,"price":9.95,"value":19880.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on February 19, 2026."}],"balance_after":13246,"source":{"system":"sec-edgar","filing":"0002048467-26-000003","document":"form4-05262026_060530.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204846726000003/form4-05262026_060530.xml","form_type":"4"}},{"id":764864,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":44481,"kind":"person","name":"Palasis Maria","position":1,"cik":"0001810701","reported_name":"Palasis Maria","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-26T22:00:33.000Z","date":"2026-05-21","kind":"grant","planned":false,"acquired":true,"shares":16965,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan."}],"balance_after":29397,"source":{"system":"sec-edgar","filing":"0001810701-26-000003","document":"form4-05262026_060528.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810701/000181070126000003/form4-05262026_060528.xml","form_type":"4"}},{"id":763759,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-26T22:00:32.000Z","date":"2026-05-21","kind":"grant","planned":false,"acquired":true,"shares":16965,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan."}],"balance_after":32209,"source":{"system":"sec-edgar","filing":"0001756438-26-000003","document":"form4-05262026_060527.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000175643826000003/form4-05262026_060527.xml","form_type":"4"}},{"id":763758,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":44222,"kind":"person","name":"CARNEY SEAN","position":1,"cik":"0001239312","reported_name":"CARNEY SEAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-26T22:00:30.000Z","date":"2026-05-21","kind":"grant","planned":false,"acquired":true,"shares":16965,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan."}],"balance_after":32209,"source":{"system":"sec-edgar","filing":"0001239312-26-000003","document":"form4-05262026_060524.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000123931226000003/form4-05262026_060524.xml","form_type":"4"}},{"id":763757,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":44221,"kind":"person","name":"Lezack Adam","position":1,"cik":"0002048466","reported_name":"Lezack Adam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Comon Stock","published_at":"2026-05-26T22:00:27.000Z","date":"2026-05-22","kind":"sale","planned":true,"acquired":false,"shares":998,"price":11.21,"value":11187.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on July 31, 2025."}],"balance_after":27399,"source":{"system":"sec-edgar","filing":"0002048466-26-000003","document":"form4-05262026_060522.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204846626000003/form4-05262026_060522.xml","form_type":"4"}},{"id":763756,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":44221,"kind":"person","name":"Lezack Adam","position":1,"cik":"0002048466","reported_name":"Lezack Adam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-26T22:00:27.000Z","date":"2026-05-21","kind":"grant","planned":true,"acquired":true,"shares":16965,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan."}],"balance_after":28397,"source":{"system":"sec-edgar","filing":"0002048466-26-000003","document":"form4-05262026_060522.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204846626000003/form4-05262026_060522.xml","form_type":"4"}},{"id":763755,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":44221,"kind":"person","name":"Lezack Adam","position":1,"cik":"0002048466","reported_name":"Lezack Adam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-26T22:00:27.000Z","date":"2026-05-21","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":9.95,"value":9950.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on July 31, 2025."}],"balance_after":11432,"source":{"system":"sec-edgar","filing":"0002048466-26-000003","document":"form4-05262026_060522.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204846626000003/form4-05262026_060522.xml","form_type":"4"}},{"id":841619,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2353,"kind":"person","name":"Hopman Mark","position":1,"cik":"0002048497","reported_name":"Hopman Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-03-16T23:55:07.000Z","date":"2025-12-04","kind":"sale","planned":true,"acquired":false,"shares":2061,"price":30.661,"value":63192.321,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 13, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The weighted average sale price for the transaction reported was $30.6610 and the range of prices were between $30.02 and $31.0024. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":136216,"source":{"system":"sec-edgar","filing":"0002048497-26-000004","document":"form4-03162026_070303.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204849726000004/form4-03162026_070303.xml","form_type":"4"}},{"id":841618,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2353,"kind":"person","name":"Hopman Mark","position":1,"cik":"0002048497","reported_name":"Hopman Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-03-16T23:55:07.000Z","date":"2025-12-02","kind":"sale","planned":true,"acquired":false,"shares":856,"price":29.3359,"value":25111.5304,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units."}],"balance_after":138277,"source":{"system":"sec-edgar","filing":"0002048497-26-000004","document":"form4-03162026_070303.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204849726000004/form4-03162026_070303.xml","form_type":"4"}},{"id":842074,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2355,"kind":"person","name":"Russell Steven Jon","position":1,"cik":"0002051384","reported_name":"Russell Steven Jon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-16T23:55:04.000Z","date":"2025-12-02","kind":"sale","planned":false,"acquired":false,"shares":1025,"price":29.3359,"value":30069.2975,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units."}],"balance_after":178071,"source":{"system":"sec-edgar","filing":"0002051384-26-000003","document":"form4-03162026_070301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2051384/000205138426000003/form4-03162026_070301.xml","form_type":"4"}},{"id":843898,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2351,"kind":"person","name":"Mensinger Mike","position":1,"cik":"0002048500","reported_name":"Mensinger Mike","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Product Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-03-13T20:15:23.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":91520,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest in 36 equal monthly installments measured from March 1, 2026."}],"balance_after":91520,"derivative":{"exercise_price":12.63,"expiration_date":"2036-02-26","underlying":"Common Stock","underlying_shares":91520},"source":{"system":"sec-edgar","filing":"0002048500-26-000006","document":"form4a-03132026_040314.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204850026000006/form4a-03132026_040314.xml","form_type":"4/A","original_submission_date":"2026-03-03"}},{"id":844302,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2355,"kind":"person","name":"Russell Steven Jon","position":1,"cik":"0002051384","reported_name":"Russell Steven Jon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-03-13T20:15:20.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":91520,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest in 36 equal monthly installments measured from March 1, 2026."}],"balance_after":91520,"derivative":{"exercise_price":12.63,"expiration_date":"2036-02-26","underlying":"Common Stock","underlying_shares":91520},"source":{"system":"sec-edgar","filing":"0002051384-26-000002","document":"form4a-03132026_040312.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2051384/000205138426000002/form4a-03132026_040312.xml","form_type":"4/A","original_submission_date":"2026-03-03"}},{"id":843897,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2356,"kind":"person","name":"Saint Sean","position":1,"cik":"0002048593","reported_name":"Saint Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-03-13T20:15:18.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":287944,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest in 36 equal monthly installments measured from March 1, 2026."}],"balance_after":287944,"derivative":{"exercise_price":12.63,"expiration_date":"2036-02-26","underlying":"Common Stock","underlying_shares":287944},"source":{"system":"sec-edgar","filing":"0002048593-26-000003","document":"form4a-03132026_040309.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204859326000003/form4a-03132026_040309.xml","form_type":"4/A","original_submission_date":"2026-03-03"}},{"id":843895,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2353,"kind":"person","name":"Hopman Mark","position":1,"cik":"0002048497","reported_name":"Hopman Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-03-13T20:15:17.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":91520,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest in 36 equal monthly installments measured from March 1, 2026."}],"balance_after":91520,"derivative":{"exercise_price":12.63,"expiration_date":"2036-02-26","underlying":"Common Stock","underlying_shares":91520},"source":{"system":"sec-edgar","filing":"0002048497-26-000003","document":"form4a-03132026_040307.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204849726000003/form4a-03132026_040307.xml","form_type":"4/A","original_submission_date":"2026-03-03"}},{"id":843896,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-03-13T20:15:14.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":110342,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest in 36 equal monthly installments measured from March 1, 2026."}],"balance_after":110342,"derivative":{"exercise_price":12.63,"expiration_date":"2036-02-26","underlying":"Common Stock","underlying_shares":110342},"source":{"system":"sec-edgar","filing":"0002048588-26-000005","document":"form4a-03132026_040304.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204858826000005/form4a-03132026_040304.xml","form_type":"4/A","original_submission_date":"2026-03-03"}},{"id":858469,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2353,"kind":"person","name":"Hopman Mark","position":1,"cik":"0002048497","reported_name":"Hopman Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-03-06T00:30:05.000Z","date":"2026-03-04","kind":"sale","planned":true,"acquired":false,"shares":353,"price":11.57,"value":4084.21,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 13, 2025."}],"balance_after":139133,"source":{"system":"sec-edgar","filing":"0002048497-26-000002","document":"form4-03062026_120301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204849726000002/form4-03062026_120301.xml","form_type":"4"}},{"id":867182,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2353,"kind":"person","name":"Hopman Mark","position":1,"cik":"0002048497","reported_name":"Hopman Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-03-03T23:45:13.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":58749,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to this option shall vest in 36 equal monthly installments measured from March 1, 2026."}],"balance_after":58749,"derivative":{"exercise_price":12.63,"expiration_date":"2036-02-26","underlying":"Common Stock","underlying_shares":58749},"source":{"system":"sec-edgar","filing":"0002048497-26-000001","document":"form4-03032026_060310.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204849726000001/form4-03032026_060310.xml","form_type":"4"}},{"id":867181,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2353,"kind":"person","name":"Hopman Mark","position":1,"cik":"0002048497","reported_name":"Hopman Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-03-03T23:45:13.000Z","date":"2026-03-02","kind":"sale","planned":false,"acquired":false,"shares":834,"price":12.3616,"value":10309.5744,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The weighted average sale price for the transaction reported was $12.3616 and the range of prices were between $12.20 and $12.55. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":139486,"source":{"system":"sec-edgar","filing":"0002048497-26-000001","document":"form4-03032026_060310.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204849726000001/form4-03032026_060310.xml","form_type":"4"}},{"id":867180,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2353,"kind":"person","name":"Hopman Mark","position":1,"cik":"0002048497","reported_name":"Hopman Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-03-03T23:45:13.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":109105,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan."}],"balance_after":140320,"source":{"system":"sec-edgar","filing":"0002048497-26-000001","document":"form4-03032026_060310.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204849726000001/form4-03032026_060310.xml","form_type":"4"}},{"id":868998,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2355,"kind":"person","name":"Russell Steven Jon","position":1,"cik":"0002051384","reported_name":"Russell Steven Jon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-03-03T23:45:12.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":58749,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to this option shall vest in 36 equal monthly installments measured from March 1, 2026."}],"balance_after":58749,"derivative":{"exercise_price":12.63,"expiration_date":"2036-02-26","underlying":"Common Stock","underlying_shares":58749},"source":{"system":"sec-edgar","filing":"0002051384-26-000001","document":"form4-03032026_060308.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2051384/000205138426000001/form4-03032026_060308.xml","form_type":"4"}},{"id":868997,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2355,"kind":"person","name":"Russell Steven Jon","position":1,"cik":"0002051384","reported_name":"Russell Steven Jon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-03T23:45:12.000Z","date":"2026-03-02","kind":"sale","planned":false,"acquired":false,"shares":1026,"price":12.3616,"value":12683.0016,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The weighted average sale price for the transaction reported was $12.3616 and the range of prices were between $12.20 and $12.55. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":179096,"source":{"system":"sec-edgar","filing":"0002051384-26-000001","document":"form4-03032026_060308.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2051384/000205138426000001/form4-03032026_060308.xml","form_type":"4"}},{"id":868996,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2355,"kind":"person","name":"Russell Steven Jon","position":1,"cik":"0002051384","reported_name":"Russell Steven Jon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-03T23:45:12.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":109105,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan."}],"balance_after":180122,"source":{"system":"sec-edgar","filing":"0002051384-26-000001","document":"form4-03032026_060308.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2051384/000205138426000001/form4-03032026_060308.xml","form_type":"4"}},{"id":867179,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2351,"kind":"person","name":"Mensinger Mike","position":1,"cik":"0002048500","reported_name":"Mensinger Mike","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Product Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-03-03T23:45:11.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":58749,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to this option shall vest in 36 equal monthly installments measured from March 1, 2026."}],"balance_after":58749,"derivative":{"exercise_price":12.63,"expiration_date":"2036-02-26","underlying":"Common Stock","underlying_shares":58749},"source":{"system":"sec-edgar","filing":"0002048500-26-000004","document":"form4-03032026_060306.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204850026000004/form4-03032026_060306.xml","form_type":"4"}},{"id":867178,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2351,"kind":"person","name":"Mensinger Mike","position":1,"cik":"0002048500","reported_name":"Mensinger Mike","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Product Officer"}}],"security":"Common Stock","published_at":"2026-03-03T23:45:11.000Z","date":"2026-03-02","kind":"sale","planned":false,"acquired":false,"shares":1064,"price":12.3616,"value":13152.7424,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The weighted average sale price for the transaction reported was $12.3616 and the range of prices were between $12.20 and $12.55. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":188793,"source":{"system":"sec-edgar","filing":"0002048500-26-000004","document":"form4-03032026_060306.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204850026000004/form4-03032026_060306.xml","form_type":"4"}},{"id":867177,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2351,"kind":"person","name":"Mensinger Mike","position":1,"cik":"0002048500","reported_name":"Mensinger Mike","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Product Officer"}}],"security":"Common Stock","published_at":"2026-03-03T23:45:11.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":109105,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan."}],"balance_after":189857,"source":{"system":"sec-edgar","filing":"0002048500-26-000004","document":"form4-03032026_060306.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204850026000004/form4-03032026_060306.xml","form_type":"4"}},{"id":867176,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-03-03T23:45:08.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":70831,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to this option shall vest in 36 equal monthly installments measured from March 1, 2026."}],"balance_after":70831,"derivative":{"exercise_price":12.63,"expiration_date":"2036-02-26","underlying":"Common Stock","underlying_shares":70831},"source":{"system":"sec-edgar","filing":"0002048588-26-000003","document":"form4-03032026_060304.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204858826000003/form4-03032026_060304.xml","form_type":"4"}},{"id":867175,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-03T23:45:08.000Z","date":"2026-03-02","kind":"sale","planned":false,"acquired":false,"shares":1428,"price":12.3616,"value":17652.3648,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The weighted average sale price for the transaction reported was $12.3616 and the range of prices were between $12.20 and $12.55. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":172729,"source":{"system":"sec-edgar","filing":"0002048588-26-000003","document":"form4-03032026_060304.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204858826000003/form4-03032026_060304.xml","form_type":"4"}},{"id":867174,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-03T23:45:08.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":131543,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan."}],"balance_after":174157,"source":{"system":"sec-edgar","filing":"0002048588-26-000003","document":"form4-03032026_060304.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204858826000003/form4-03032026_060304.xml","form_type":"4"}},{"id":867173,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2356,"kind":"person","name":"Saint Sean","position":1,"cik":"0002048593","reported_name":"Saint Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-03-03T23:45:07.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":184837,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to this option shall vest in 36 equal monthly installments measured from March 1, 2026."}],"balance_after":184837,"derivative":{"exercise_price":12.63,"expiration_date":"2036-02-26","underlying":"Common Stock","underlying_shares":184837},"source":{"system":"sec-edgar","filing":"0002048593-26-000001","document":"form4-03032026_060302.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204859326000001/form4-03032026_060302.xml","form_type":"4"}},{"id":867172,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2356,"kind":"person","name":"Saint Sean","position":1,"cik":"0002048593","reported_name":"Saint Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-03-03T23:45:07.000Z","date":"2026-03-02","kind":"sale","planned":false,"acquired":false,"shares":3384,"price":12.3616,"value":41831.6544,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The weighted average sale price for the transaction reported was $12.3616 and the range of prices were between $12.20 and $12.55. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":437809,"source":{"system":"sec-edgar","filing":"0002048593-26-000001","document":"form4-03032026_060302.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204859326000001/form4-03032026_060302.xml","form_type":"4"}},{"id":867171,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2356,"kind":"person","name":"Saint Sean","position":1,"cik":"0002048593","reported_name":"Saint Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-03-03T23:45:07.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":343269,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan."}],"balance_after":441193,"source":{"system":"sec-edgar","filing":"0002048593-26-000001","document":"form4-03032026_060302.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204859326000001/form4-03032026_060302.xml","form_type":"4"}},{"id":939212,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":44224,"kind":"person","name":"MICHEL GERARD J","position":1,"cik":"0001235644","reported_name":"MICHEL GERARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-15T01:30:13.000Z","date":"2026-01-13","kind":"grant","planned":false,"acquired":true,"shares":3997,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan."}],"balance_after":16544,"source":{"system":"sec-edgar","filing":"0001235644-26-000002","document":"form4-01142026_080110.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000123564426000002/form4-01142026_080110.xml","form_type":"4"}},{"id":939213,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":44222,"kind":"person","name":"CARNEY SEAN","position":1,"cik":"0001239312","reported_name":"CARNEY SEAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-15T01:30:11.000Z","date":"2026-01-13","kind":"grant","planned":false,"acquired":true,"shares":3997,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan."}],"balance_after":15244,"source":{"system":"sec-edgar","filing":"0001239312-26-000002","document":"form4-01142026_080108.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000123931226000002/form4-01142026_080108.xml","form_type":"4"}},{"id":939678,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":44481,"kind":"person","name":"Palasis Maria","position":1,"cik":"0001810701","reported_name":"Palasis Maria","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-15T01:30:10.000Z","date":"2026-01-13","kind":"grant","planned":false,"acquired":true,"shares":3997,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan."}],"balance_after":12432,"source":{"system":"sec-edgar","filing":"0001810701-26-000002","document":"form4-01142026_080107.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810701/000181070126000002/form4-01142026_080107.xml","form_type":"4"}},{"id":939211,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":35373,"kind":"person","name":"Jones Christy","position":1,"cik":"0002048467","reported_name":"Jones Christy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-15T01:30:08.000Z","date":"2026-01-13","kind":"grant","planned":false,"acquired":true,"shares":3997,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan."}],"balance_after":15244,"source":{"system":"sec-edgar","filing":"0002048467-26-000002","document":"form4-01142026_080105.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204846726000002/form4-01142026_080105.xml","form_type":"4"}},{"id":939210,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":44221,"kind":"person","name":"Lezack Adam","position":1,"cik":"0002048466","reported_name":"Lezack Adam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-15T01:30:06.000Z","date":"2026-01-13","kind":"grant","planned":false,"acquired":true,"shares":3997,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan."}],"balance_after":12432,"source":{"system":"sec-edgar","filing":"0002048466-26-000002","document":"form4-01142026_080103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204846626000002/form4-01142026_080103.xml","form_type":"4"}},{"id":939209,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-15T01:30:04.000Z","date":"2026-01-13","kind":"grant","planned":false,"acquired":true,"shares":3997,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan."}],"balance_after":15244,"source":{"system":"sec-edgar","filing":"0001756438-26-000002","document":"form4-01142026_080101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000175643826000002/form4-01142026_080101.xml","form_type":"4"}},{"id":944517,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2351,"kind":"person","name":"Mensinger Mike","position":1,"cik":"0002048500","reported_name":"Mensinger Mike","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Product Officer"}}],"security":"Common Stock","published_at":"2026-01-07T21:16:36.000Z","date":"2026-01-06","kind":"sale","planned":true,"acquired":false,"shares":2200,"price":30.1005,"value":66221.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on September 8, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $30.1005 and the range of prices were between $30.00 and $30.13. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":80752,"source":{"system":"sec-edgar","filing":"0002048500-26-000003","document":"form4-01072026_090132.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204850026000003/form4-01072026_090132.xml","form_type":"4"}},{"id":951511,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2351,"kind":"person","name":"Mensinger Mike","position":1,"cik":"0002048500","reported_name":"Mensinger Mike","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Product Officer"}}],"security":"Common Stock","published_at":"2026-01-05T23:05:25.000Z","date":"2026-01-02","kind":"sale","planned":true,"acquired":false,"shares":600,"price":30.1969,"value":18118.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on September 8, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The weighted average sale price for the transaction reported was $30.1969 and the range of prices were between $30.10 and $30.52. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":82952,"source":{"system":"sec-edgar","filing":"0002048500-26-000002","document":"form4-01052026_110121.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204850026000002/form4-01052026_110121.xml","form_type":"4"}},{"id":951510,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2351,"kind":"person","name":"Mensinger Mike","position":1,"cik":"0002048500","reported_name":"Mensinger Mike","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Product Officer"}}],"security":"Common Stock","published_at":"2026-01-05T23:05:25.000Z","date":"2026-01-02","kind":"sale","planned":true,"acquired":false,"shares":7200,"price":29.56,"value":212832.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on September 8, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $29.56 and the range of prices were between $29.05 and $30.02. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":83552,"source":{"system":"sec-edgar","filing":"0002048500-26-000002","document":"form4-01052026_110121.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204850026000002/form4-01052026_110121.xml","form_type":"4"}},{"id":951508,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-01-05T23:03:53.000Z","date":"2026-01-02","kind":"exercise","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023."}],"balance_after":49695,"derivative":{"exercise_price":5.1,"expiration_date":"2033-09-13","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0002048588-26-000002","document":"form4-01052026_110150.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204858826000002/form4-01052026_110150.xml","form_type":"4"}},{"id":951507,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-01-05T23:03:53.000Z","date":"2026-01-02","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":29.534,"value":590680.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 15, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $29.534002 and the range of prices were between $29.09 and $30.06. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":42614,"source":{"system":"sec-edgar","filing":"0002048588-26-000002","document":"form4-01052026_110150.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204858826000002/form4-01052026_110150.xml","form_type":"4"}},{"id":951506,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-01-05T23:03:53.000Z","date":"2026-01-02","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":5.1,"value":102000.0,"ownership":{"direct":true},"balance_after":62614,"source":{"system":"sec-edgar","filing":"0002048588-26-000002","document":"form4-01052026_110150.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204858826000002/form4-01052026_110150.xml","form_type":"4"}},{"id":980312,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2351,"kind":"person","name":"Mensinger Mike","position":1,"cik":"0002048500","reported_name":"Mensinger Mike","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Product Officer"}}],"security":"Common Stock","published_at":"2025-12-04T21:20:10.000Z","date":"2025-12-02","kind":"sale","planned":false,"acquired":false,"shares":1063,"price":29.3359,"value":31184.0617,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units."}],"balance_after":90752,"source":{"system":"sec-edgar","filing":"0002048500-25-000004","document":"form4-12042025_041205.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204850025000004/form4-12042025_041205.xml","form_type":"4"}},{"id":980310,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-12-04T21:20:07.000Z","date":"2025-12-02","kind":"sale","planned":false,"acquired":false,"shares":1427,"price":29.3359,"value":41862.3293,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units."}],"balance_after":42614,"source":{"system":"sec-edgar","filing":"0002048588-25-000008","document":"form4-12042025_041203.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204858825000008/form4-12042025_041203.xml","form_type":"4"}},{"id":980311,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2356,"kind":"person","name":"Saint Sean","position":1,"cik":"0002048593","reported_name":"Saint Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-12-04T21:20:04.000Z","date":"2025-12-02","kind":"sale","planned":false,"acquired":false,"shares":3278,"price":29.3359,"value":96163.0802,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units."}],"balance_after":97924,"source":{"system":"sec-edgar","filing":"0002048593-25-000005","document":"form4-12042025_041201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204859325000005/form4-12042025_041201.xml","form_type":"4"}},{"id":983555,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":44221,"kind":"person","name":"Lezack Adam","position":1,"cik":"0002048466","reported_name":"Lezack Adam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-02T21:20:08.000Z","date":"2025-12-01","kind":"sale","planned":true,"acquired":false,"shares":500,"price":29.91,"value":14955.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on July 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The weighted average sale price for the transaction reported was $29.91 and the range of prices were between $29.80 and $30.16. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":8435,"source":{"system":"sec-edgar","filing":"0002048466-25-000005","document":"form4-12022025_041204.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204846625000005/form4-12022025_041204.xml","form_type":"4"}},{"id":983554,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":44221,"kind":"person","name":"Lezack Adam","position":1,"cik":"0002048466","reported_name":"Lezack Adam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-02T21:20:08.000Z","date":"2025-12-01","kind":"sale","planned":true,"acquired":false,"shares":906,"price":29.3463,"value":26587.7478,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on July 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $29.3463 and the range of prices were between $28.75 and $29.63. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":8935,"source":{"system":"sec-edgar","filing":"0002048466-25-000005","document":"form4-12022025_041204.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204846625000005/form4-12022025_041204.xml","form_type":"4"}},{"id":984404,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":44481,"kind":"person","name":"Palasis Maria","position":1,"cik":"0001810701","reported_name":"Palasis Maria","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-02T21:20:06.000Z","date":"2025-12-01","kind":"sale","planned":true,"acquired":false,"shares":500,"price":29.964,"value":14982.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on July 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The weighted average sale price for the transaction reported was $29.9640 and the range of prices were between $29.80 and $30.23. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":8435,"source":{"system":"sec-edgar","filing":"0001810701-25-000007","document":"form4-12022025_041202.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1810701/000181070125000007/form4-12022025_041202.xml","form_type":"4"}},{"id":984403,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":44481,"kind":"person","name":"Palasis Maria","position":1,"cik":"0001810701","reported_name":"Palasis Maria","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-02T21:20:06.000Z","date":"2025-12-01","kind":"sale","planned":true,"acquired":false,"shares":906,"price":29.3269,"value":26570.1714,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on July 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $29.3269 and the range of prices were between $28.75 and $29.63. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":8935,"source":{"system":"sec-edgar","filing":"0001810701-25-000007","document":"form4-12022025_041202.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810701/000181070125000007/form4-12022025_041202.xml","form_type":"4"}},{"id":1006828,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":44221,"kind":"person","name":"Lezack Adam","position":1,"cik":"0002048466","reported_name":"Lezack Adam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-06T02:45:07.000Z","date":"2025-10-31","kind":"sale","planned":true,"acquired":false,"shares":38,"price":27.7,"value":1052.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on July 31, 2025."}],"balance_after":9841,"source":{"system":"sec-edgar","filing":"0002048466-25-000003","document":"form4-11052025_091104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204846625000003/form4-11052025_091104.xml","form_type":"4"}},{"id":1006827,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":44221,"kind":"person","name":"Lezack Adam","position":1,"cik":"0002048466","reported_name":"Lezack Adam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-06T02:45:07.000Z","date":"2025-10-31","kind":"sale","planned":true,"acquired":false,"shares":1368,"price":26.8474,"value":36727.2432,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on July 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $26.8474 and the range of prices were between $26.27 and $27.24. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":9879,"source":{"system":"sec-edgar","filing":"0002048466-25-000003","document":"form4-11052025_091104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204846625000003/form4-11052025_091104.xml","form_type":"4"}},{"id":1007495,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":44481,"kind":"person","name":"Palasis Maria","position":1,"cik":"0001810701","reported_name":"Palasis Maria","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-06T02:45:06.000Z","date":"2025-10-31","kind":"sale","planned":true,"acquired":false,"shares":119,"price":27.4502,"value":3266.5738,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on July 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The weighted average sale price for the transaction reported was $27.4502 and the range of prices were between $27.32 and $27.57. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":9841,"source":{"system":"sec-edgar","filing":"0001810701-25-000005","document":"form4-11052025_091101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1810701/000181070125000005/form4-11052025_091101.xml","form_type":"4"}},{"id":1007494,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":44481,"kind":"person","name":"Palasis Maria","position":1,"cik":"0001810701","reported_name":"Palasis Maria","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-06T02:45:06.000Z","date":"2025-10-31","kind":"sale","planned":true,"acquired":false,"shares":1287,"price":26.8588,"value":34567.2756,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on July 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $26.8588 and the range of prices were between $26.27 and $27.22. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":9960,"source":{"system":"sec-edgar","filing":"0001810701-25-000005","document":"form4-11052025_091101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810701/000181070125000005/form4-11052025_091101.xml","form_type":"4"}},{"id":1022215,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-10-07T20:15:05.000Z","date":"2025-10-03","kind":"exercise","planned":true,"acquired":false,"shares":4982,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023."}],"balance_after":69695,"derivative":{"exercise_price":5.1,"expiration_date":"2033-09-13","underlying":"Common Stock","underlying_shares":4982},"source":{"system":"sec-edgar","filing":"0002048588-25-000004","document":"form4-10072025_041001.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204858825000004/form4-10072025_041001.xml","form_type":"4"}},{"id":1022214,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-10-07T20:15:05.000Z","date":"2025-10-03","kind":"sale","planned":true,"acquired":false,"shares":1154,"price":22.2778,"value":25708.5812,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 15, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The weighted average sale price for the transaction reported was $22.2778 and the range of prices were between $22.0438 and $22..47. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":44041,"source":{"system":"sec-edgar","filing":"0002048588-25-000004","document":"form4-10072025_041001.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204858825000004/form4-10072025_041001.xml","form_type":"4"}},{"id":1022213,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-10-07T20:15:05.000Z","date":"2025-10-03","kind":"sale","planned":true,"acquired":false,"shares":3828,"price":21.5172,"value":82367.8416,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 15, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $21.5172 and the range of prices were between $21.04 and $22.0144. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":45195,"source":{"system":"sec-edgar","filing":"0002048588-25-000004","document":"form4-10072025_041001.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204858825000004/form4-10072025_041001.xml","form_type":"4"}},{"id":1022212,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-10-07T20:15:05.000Z","date":"2025-10-03","kind":"exercise","planned":true,"acquired":true,"shares":4982,"price":5.1,"value":25408.2,"ownership":{"direct":true},"balance_after":49023,"source":{"system":"sec-edgar","filing":"0002048588-25-000004","document":"form4-10072025_041001.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204858825000004/form4-10072025_041001.xml","form_type":"4"}},{"id":1024578,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-10-03T20:31:50.000Z","date":"2025-10-01","kind":"exercise","planned":true,"acquired":false,"shares":15018,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023."}],"balance_after":74677,"derivative":{"exercise_price":5.1,"expiration_date":"2033-09-13","underlying":"Common Stock","underlying_shares":15018},"source":{"system":"sec-edgar","filing":"0002048588-25-000003","document":"form4-10032025_081044.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204858825000003/form4-10032025_081044.xml","form_type":"4"}},{"id":1024577,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-10-03T20:31:50.000Z","date":"2025-10-01","kind":"sale","planned":true,"acquired":false,"shares":100,"price":21.08,"value":2108.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 15, 2025."}],"balance_after":44041,"source":{"system":"sec-edgar","filing":"0002048588-25-000003","document":"form4-10032025_081044.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204858825000003/form4-10032025_081044.xml","form_type":"4"}},{"id":1024576,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-10-03T20:31:50.000Z","date":"2025-10-01","kind":"sale","planned":true,"acquired":false,"shares":14918,"price":20.76,"value":309697.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 15, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $20.76 and the range of prices were between $20.03 and $21.03. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":44141,"source":{"system":"sec-edgar","filing":"0002048588-25-000003","document":"form4-10032025_081044.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204858825000003/form4-10032025_081044.xml","form_type":"4"}},{"id":1024575,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-10-03T20:31:50.000Z","date":"2025-10-01","kind":"exercise","planned":true,"acquired":true,"shares":15018,"price":5.1,"value":76591.8,"ownership":{"direct":true},"balance_after":59059,"source":{"system":"sec-edgar","filing":"0002048588-25-000003","document":"form4-10032025_081044.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204858825000003/form4-10032025_081044.xml","form_type":"4"}},{"id":1044792,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-09-09T20:12:26.000Z","date":"2025-09-08","kind":"exercise","planned":true,"acquired":false,"shares":9900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023."}],"balance_after":89695,"derivative":{"exercise_price":5.1,"expiration_date":"2033-09-13","underlying":"Common Stock","underlying_shares":9900},"source":{"system":"sec-edgar","filing":"0001415889-25-023969","document":"form4-09092025_080923.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925023969/form4-09092025_080923.xml","form_type":"4"}},{"id":1044791,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-09-09T20:12:26.000Z","date":"2025-09-08","kind":"sale","planned":true,"acquired":false,"shares":9900,"price":21.1264,"value":209151.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 15, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $21.126480 and the range of prices were between $21.00 and $21.2933. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":44041,"source":{"system":"sec-edgar","filing":"0001415889-25-023969","document":"form4-09092025_080923.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925023969/form4-09092025_080923.xml","form_type":"4"}}],"next_cursor":"2025-09-09T20:12:26.000000Z,1044791"}